表紙
市場調查報告書
商品編碼
974918

基於隔離器的無菌灌裝系統市場(2020-2030)

Isolator based Aseptic Filling Systems Market, 2020-2030

出版日期: | 出版商: Roots Analysis | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

灌裝/精加工過程被認為是製藥生產的重要方面。因此,製藥公司需要確保封裝在主容器中的製劑安全食用/給藥。儘管已被很好地建立起來,但現代藥物灌裝工藝仍存在著污染風險,灌裝錯誤(劑量分配不準確)以及與標籤相關的問題。實際上,行業專家認為,大約80%的產品召回可能是由於包裝方面的問題。

污染是與灌裝/塗飾操作相關的關鍵問題之一。為了確保消費者的安全,在灌裝/精加工階段已盡力保持無菌環境。在這方面,在灌裝線中進行人工干預不僅威脅到產品安全(容易受到與工人接觸的污染),而且效率低下。多年來,隨著現代醫學(尤其是生物製藥和複雜的小分子API)的複雜性增加,相應地需要使諸如填充/整理等常規重複任務自動化。結果,在專用設備和基礎設施以及處理專業知識方面,藥物填充過程變得越來越苛刻。

多年來,製藥設備製造商已經在自己的□□灌裝線上開發了高效,可靠且具有成本效益的機器,包括隔離器和進入限制屏障系統(RABS)。這些系統中的許多系統旨在消除人工干預的需要,從而解決了與操作員相關的污染風險。此外,使用灌裝線將設備的各個部分分開,這大大節省了成本。在這種情況下,開發人員無需投資大型高端潔淨室來容納灌裝線。目前,市場上有超過130種基於隔離器的灌裝和封閉系統,設備開發人員仍在努力進行進一步的改進。鑑於目前有超過5,000種生物藥品正在開發中,無菌灌裝/後處理設備的市場機會預計將在未來十年中繼續以顯著速度增長。

本報告分析了基於隔離器的無菌灌裝系統的全球市場,概述了技術,市場的基本結構,相關法規的趨勢,按細分市場的最新市場狀況和趨勢以及公司之間的競爭趨勢。主要公司簡介,整體市場趨勢展望(2020-2030年),當前問題和未來市場機會等。

目錄

第1章簡介

第2章執行摘要

第3章簡介

  • 分析摘要
  • 藥物填充/完成過程概述
  • 無菌灌裝/塗飾技術
  • 需要無菌灌裝/整理
  • 常規無菌灌裝/整理過程
  • 先進的無菌灌裝/精加工工藝:吹氣-灌裝-密封無菌技術
    • 隔離系統
    • 訪問限制屏障系統(RABS)
    • 隔離系統與RABS的比較
  • 先進的無菌灌裝/塗飾技術的優勢
  • 無菌灌裝/後整理法規指南
  • 未來展望

第4章基於隔離器的無菌灌裝系統:當前市場狀況

  • 分析摘要
  • 基於隔離器的無菌灌裝系統:市場概述
    • 按系統類型分析
    • 按經營規模分析
    • 按系統吞吐量分析
    • 一次包裝的兼容性分析
    • 按劑型類型分析
    • 填充量範圍分析
  • 基於隔離器的無菌灌裝系統:公司發展狀況
    • 成立年份分析
    • 按公司規模分析
    • 總公司所在地分析
    • 主要公司:按專用系統數量分析

第5章基於隔離器的無菌灌裝/封閉裝置:產品競爭力分析

  • 分析摘要
  • 分析方法和主要參數
  • 產品競爭力分析:第一類同行
  • 產品競爭力分析:第二類同行
  • 產品競爭力分析:第三類同行

第6章公司簡介

  • AST
    • 公司簡介
    • 最新趨勢和未來前景
  • Bausch+Strobel
  • Dara Pharmaceutical Packaging
  • Groninger
  • IMA Group
  • Marchesini Group
  • OPTIMA Packaging Group
  • Syntegon
  • Tofflon Group
  • Vanrx Pharmasystems

第7章最新趨勢

  • 分析摘要
  • 商業聯盟(夥伴關係)模型
  • 基於隔離器的無菌灌裝系統市場:業務聯盟
    • 商業聯盟/合作清單
  • 基於隔離器的無菌灌裝系統市場:最近的展覽和會議
    • 最近展覽/會議列表
  • 結論

第8章監管指南:無菌處理

  • 分析摘要
  • 潔淨室等級:概述
  • 無菌治療的一般準則
    • 建築物/設施要求
    • 人力資源培訓,資格,監控要求
    • 組件/容器/封閉要求
  • 使用隔離器技術的準則
  • 使用吹填密封技術的準則

第9章市場預測

  • 分析摘要
  • 預測方法和主要前提
  • 全球市場規模:按運營規模分(2020-2030)
  • 全球市場規模:按主要集裝箱類型分類(2020-2030年)
  • 全球市場規模:按系統吞吐量(2020-2030年)
  • 全球市場規模:按最終用戶劃分(2020-2030)
  • 北美基於隔離器的無菌灌裝系統市場
    • 市場規模:按運營規模(2020-2030年)
    • 市場規模:按主要集裝箱類型分類(2020-2030年)
    • 市場規模:按系統吞吐量(2020-2030年)
    • 市場規模:最終用戶(2020-2030)
  • 基於歐洲隔離器的無菌灌裝系統市場
  • 基於亞太隔離器的無菌灌裝系統市場
  • 其他國家基於隔離器的無菌灌裝系統市場(RoW)

第10章結論

第11章管理層的考慮/觀點

  • 分析摘要
  • Automated Systems of Tacoma (AST)
    • 採訪記錄

第12章附錄1:匯總數據

第13章附錄2:公司/組織列表

目錄

Overview:

Fill / finish is considered a critical aspect of pharmaceutical manufacturing. It is, therefore, imperative for drug manufacturers to ensure that formulations enclosed in primary containers are safe for consumption / administration. Despite being well established, there are several concerns associated with the contemporary drug filling process, such as the risk of contamination, filling errors (inaccurate dose dispensation) , and labelling-related issues. In fact, experts in the industry believe that around 80% of product recalls may be attributed to packaging-related concerns. Contamination is one of the key concerns related to fill / finish operations. To ensure the safety of consumers, a lot of effort is put into maintaining an aseptic environment during the fill / finish step. In this regard, manual intervention in filling lines is not only a threat to product safety (being more susceptible to contamination from contact with laborers) , but also inefficient. Over the years, the growing complexity of modern pharmaceuticals (especially biologic drugs and complex small molecule APIs) , has created a corresponding need for the automation of routine, repetitive tasks, such as fill / finish. As a result, the drug filling process is gradually becoming more demanding, in terms of specialized equipment and infrastructure, and handling expertise.

Over the past couple of decades, pharma equipment manufacturers have developed more efficient, reliable and cost-effective machinery, involving the required isolators and restricted access barrier systems (RABS), to their proprietary filling lines. Many of such systems are designed to eliminate the need for human intervention, thereby, addressing the risk of operator-associated contamination. In addition, the use of filling lines where parts of the equipment are individually isolated, has been associated with notable cost saving opportunities. In such cases, developers need not invest in large, high-end cleanrooms for housing such filling lines. Currently, over 130 isolator-based filling and closing systems are available in the market, and equipment developers are still engaged in further improvement efforts.Given that more than 5,000 biopharmaceutical product candidates are currently under development, the opportunity for aseptic fill / finish equipment developers is anticipated to continue to grow at a substantial pace over the next decade.

Scope of the Report:

The 'Isolator based Aseptic Filling Systems Market, 2020-2030' report features an extensive study of the current landscape of isolator based aseptic filling systems and the future opportunities associated with such systems. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

In addition to other elements, the report features:

  • A detailed assessment of the overall landscape of the isolator based aseptic filling systems, highlighting the contribution of industry players and providing information on various types of systems (filling, and turnkey solutions), scale of operation (clinical and commercial), system throughput, compatible primary containers (ampoules, bottles, capsules, cartridges, syringes, vials and others), type of formulation and range of fill volume.
  • An insightful competitiveness analysis of isolator based aseptic filling systems, taking into consideration the scale of operation, system throughput, compatible primary containers, type of formulation and other important product related specifications.
  • Elaborate profiles of companies offering isolator based aseptic filling systems. Each profile features a brief overview of the company, its financial information (if available), proprietary product(s), recent developments and an informed future outlook.
  • A discussion on general regulatory guidelines for aseptic processing, and specific recommendations related to isolator and blow / fill / seal technologies used in the aseptic fill / finish process.
  • An analysis of various developments / recent trends related to aseptic processing market, offering insights on [A] partnerships and collaborations established within the industry, and [B] conferences held in this space.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future opportunity within the market. Based on several parameters, such as annual fill / finish pharma capacity, number of automatic filling lines installed and growth trends across various geographies, we have provided an informed estimate of the likely evolution of the market, in the mid to long term, for the period 2020-2030. The chapter features the likely distribution of the opportunity across [A] scale of operation (clinical and commercial), [B] type of compatible primary container (ampoules, bottles, capsules, cartridges, syringes, vials and others), [C] system throughput (low throughput, medium throughput and high throughput), [D] end-user (pharmaceutical companies, contract service providers and others) and [E] geographical regions (North America, Europe, Asia-Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market's evolution.

The opinions and insights presented in this study were influenced by discussions conducted with stakeholders in this domain.

All actual figures have been sourced and analyzed from publicly available information forums. Financial figures mentioned in this report are in USD, unless otherwise specified.

Chapter Outlines:

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the likely evolution of the aseptic filling systems market in the mid to long term.

Chapter 3 provides an overview of drug fill / finish process, and various aseptic fill / finish techniques. It also highlights the need for aseptic fill / finish in drug manufacturing, and various traditional and advanced aseptic fill / finish techniques currently being used in the pharma industry. Further, the chapter highlights a comparison between isolator and RABS systems, as well as various advantages associated with the advanced aseptic fill / finish methods and its future perspectives.

Chapter 4 provides an overview of the overall landscape of the isolator based aseptic filling systems, highlighting the contribution of industry players and providing information on various types of systems (filling, and turnkey solutions), scale of operation (clinical and commercial), system throughput, compatible primary containers (ampoules, bottles, capsules, cartridges, syringes, vials and others), type of formulation and range of fill volume.

Chapter 5 provides a detailed insightful competitiveness analysis of isolator based aseptic filling systems, taking into consideration the scale of operation, system throughput, compatible primary containers, type of formulation and other important product related specifications.

Chapter 6 includes detailed profiles of the companies offering isolator based aseptic filling systems. Each profile features a brief overview of the company, its financial information (if available), proprietary product(s), recent developments and an informed future outlook.

Chapter 7 providers general regulatory guidelines for aseptic processing, and specific recommendations related to isolator and blow / fill / seal technologies used in the aseptic fill / finish process.

Chapter 8 provides an analysis of various developments / recent trends related to aseptic processing market, offering insights on [A] partnerships and collaborations established within the industry, and [B] conferences held in this space.

Chapter 9 presents a detailed market forecast, highlighting the distribution of the opportunity across [A] scale of operation (clinical and commercial), [B] type of compatible primary container (ampoules, bottles, capsules, cartridges, syringes, vials and others), [C] system throughput (low throughput, medium throughput and high throughput), [D] end-user (pharmaceutical companies, contract service providers and others) and [E] geographical regions (North America, Europe, Asia-Pacific and rest of the world).

Chapter 10 summarizes the entire report. It presents a list of key takeaways and offers our independent opinion on the current market scenario. Further, it summarizes the various evolutionary trends that are likely to influence the future of this market.

Chapter 11 is a collection of executive insight(s) of the discussion(s) that were held with key stakeholder(s) in this market.

Chapter 12 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Overview of Drug Fill / Finish Processes
  • 3.3. Aseptic Fill / Finish Technique
  • 3.4. Need for Aseptic Fill / Finish
  • 3.5. Traditional Aseptic Fill / Finish Processes
  • 3.6. Advanced Aseptic Fill / Finish Processes: Blow-Fill-Seal Aseptic Technology
    • 3.6.1. Isolator Systems
    • 3.6.2. Restricted Access Barrier Systems (RABS)
    • 3.6.3. Comparison between Isolator Systems and RABS
  • 3.7. Advantages of Advanced Aseptic Fill / Finish Techniques
  • 3.8. Regulatory Guidelines for Aseptic Fill / Finish
  • 3.9. Future Perspectives

4. ISOLATOR BASED ASEPTIC FILLING SYSTEMS: CURRENT MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Isolator based Aseptic Filling Systems: Overall Market Overview
    • 4.2.1. Analysis by Type of System
    • 4.2.2. Analysis by Scale of Operation
    • 4.2.4. Analysis by System Throughput
    • 4.2.5. Analysis by Compatible Primary Container(s)
    • 4.2.6. Analysis by Type of Formulation
    • 4.2.7. Analysis by Fill Volume Range
  • 4.3. Isolator based Aseptic Filling Systems: Developer Landscape
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Location of Headquarters
    • 4.3.4. Leading Players: Analysis by Number of Proprietary Systems

5. ISOLATOR BASED ASEPTIC FILLING AND CLOSING SYSTEMS: PRODUCT COMPETITIVENESS ANALYSIS

  • 5.1. Chapter Overview
  • 5.2. Methodology and Key Parameters
  • 5.3. Product Competitiveness Analysis: Peer Group I
  • 5.4. Product Competitiveness Analysis: Peer Group II
  • 5.5. Product Competitiveness Analysis: Peer Group III

6. COMPANY PROFILES

  • 6.1. AST
    • 6.1.1. Company Overview
    • 6.1.2. Recent Developments and Future Outlook
  • 6.2. Bausch+Ströbel
    • 6.2.1. Company Overview
    • 6.2.2. Recent Developments and Future Outlook
  • 6.3. Dara Pharmaceutical Packaging
    • 6.3.1. Company Overview
    • 6.3.2. Recent Developments and Future Outlook
  • 6.4. Groninger
    • 6.4.1. Company Overview
    • 6.4.2. Recent Developments and Future Outlook
  • 6.5. IMA Group
    • 6.5.1. Company Overview
    • 6.5.2. Recent Developments and Future Outlook
  • 6.6. Marchesini Group
    • 6.6.1. Company Overview
    • 6.6.2. Recent Developments and Future Outlook
  • 6.7. OPTIMA Packaging Group
    • 6.7.1. Company Overview
    • 6.7.2. Recent Developments and Future Outlook
  • 6.8. Syntegon
    • 6.8.1. Company Overview
    • 6.8.2. Recent Developments and Future Outlook
  • 6.9. Tofflon Group
    • 6.9.1. Company Overview
    • 6.9.2. Recent Developments and Future Outlook
  • 6.10. Vanrx Pharmasystems
    • 6.10.1. Company Overview
    • 6.10.2. Recent Developments and Future Outlook

7. RECENT DEVELOPMENTS

  • 7.1. Chapter Overview
  • 7.2. Partnership Models
  • 7.3. Isolator based Aseptic Filling Systems Market: Partnership Activity
    • 7.3.1. List of Partnerships and Collaborations
      • 7.3.2.1. Analysis by Year of Partnership
      • 7.3.2.2. Analysis by Type of Partnership
      • 7.3.2.3. Analysis by Focus Area
      • 7.3.2.4. Most Active Players: Analysis by Number of Partnerships
  • 7.4. Isolator based Aseptic Filling Systems Market: Recent Conferences
    • 7.4.1. List of Recent Conferences
      • 7.4.1.1. Analysis by Year of Occurrence
      • 7.4.1.2. Analysis by Geography
  • 7.4. Concluding Remarks

8. REGULATORY GUIDELINES: ASEPTIC PROCESSING

  • 8.1. Chapter Overview
  • 8.2. Overview of Cleanroom Grades
  • 8.3. General Guidelines for Aseptic Processing
    • 8.3.1. Requirements for Buildings and Facilities
    • 8.3.2. Requirements for Personnel Training, Qualification and Monitoring
    • 8.3.3. Requirements for Components and Containers / Closures
  • 8.4. Guidelines for Using Isolator Technology
  • 8.5. Guidelines for Using Blow / Fill / Seal Technology

9. MARKET FORECAST

  • 9.1. Chapter Overview
  • 9.2. Forecast Methodology and Key Assumptions
  • 9.3. Overall Isolator based Aseptic Filling Systems Market, 2020-2030
  • 9.4. Overall Isolator based Aseptic Filling Systems Market: Distribution by Scale of Operation, 2020-2030
  • 9.5. Overall Isolator based Aseptic Filling Systems Market: Distribution by Type of Compatible Primary Container, 2020-2030
  • 9.6. Overall Isolator based Aseptic Filling Systems Market: Distribution by System Throughput, 2020-2030
  • 9.7. Overall Isolator based Aseptic Filling Systems Market: Distribution by End-User, 2020-2030
  • 9.8. Overall Isolator based Aseptic Filling Systems Market in North America, 2020-2030
    • 9.8.1. Isolator based Aseptic Filling Systems Market in North America: Distribution by Scale of Operation, 2020-2030
      • 9.8.1.1. Isolator based Aseptic Filling Systems Market in North America: Share of Clinical Scale Systems, 2020-2030
      • 9.8.1.2. Isolator based Aseptic Filling Systems Market in North America: Share of Commercial Scale Systems, 2020-2030
    • 9.8.2. Isolator based Aseptic Filling Systems Market in North America: Distribution by Type of Compatible Primary Container, 2020-2030
      • 9.8.2.1. Isolator based Aseptic Filling Systems Market in North America: Share of Ampoules, 2020-2030
      • 9.8.2.2. Isolator based Aseptic Filling Systems Market in North America: Share of Bottles, 2020-2030
      • 9.8.2.3. Isolator based Aseptic Filling Systems Market in North America: Share of Capsules, 2020-2030
      • 9.8.2.4. Isolator based Aseptic Filling Systems Market in North America: Share of Cartridges, 2020-2030
      • 9.8.2.5. Isolator based Aseptic Filling Systems Market in North America: Share of Syringes, 2020-2030
      • 9.8.2.6. Isolator based Aseptic Filling Systems Market in North America: Share of Vials, 2020-2030
      • 9.8.2.7. Isolator based Aseptic Filling Systems Market in North America: Share of Other Primary Containers, 2020-2030
    • 9.8.3. Isolator based Aseptic Filling Systems Market in North America: Distribution by System Throughput, 2020-2030
      • 9.8.3.1. Isolator based Aseptic Filling Systems Market in North America: Share of Low Throughput Systems, 2020-2030
      • 9.8.3.2. Isolator based Aseptic Filling Systems Market in North America: Share of Medium Throughput Systems, 2020-2030
      • 9.8.3.4. Isolator based Aseptic Filling Systems Market in North America: Share of High Throughput Systems, 2020-2030
    • 9.8.4. Isolator based Aseptic Filling Systems Market in North America: Distribution by End-User, 2020-2030
    • 9.8.4.1 Isolator based Aseptic Filling Systems Market in North America: Share of Contract Service Providers, 2020-2030
    • 9.8.4.2 Isolator based Aseptic Filling Systems Market in North America: Share of Pharmaceutical Companies, 2020-2030
    • 9.8.4.3 Other End-Users, 2020-2030Isolator based Aseptic Filling Systems Market in North America: Share of Other End-Users, 2020-2030
  • 9.9. Overall Isolator based Aseptic Filling Systems Market in Europe, 2020-2030
    • 9.9.1. Isolator based Aseptic Filling Systems Market in Europe: Distribution by Scale of Operation, 2020-2030
    • 9.9.1.1 Isolator based Aseptic Filling Systems Market in Europe: Share of Clinical Scale Systems, 2020-2030
      • 9.9.1.2. Isolator based Aseptic Filling Systems Market in Europe: Share of Commercial Scale Systems, 2020-2030
    • 9.9.2. Isolator based Aseptic Filling Systems Market in Europe: Distribution by Type of Compatible Primary Container, 2020-2030
      • 9.9.2.1. Isolator based Aseptic Filling Systems Market in Europe: Share of Ampoules, 2020-2030
      • 9.9.2.2. Isolator based Aseptic Filling Systems Market in Europe: Share of Bottles, 2020-2030
      • 9.9.2.3. Isolator based Aseptic Filling Systems Market in Europe: Share of Capsules, 2020-2030
      • 9.9.2.4. Isolator based Aseptic Filling Systems Market in Europe: Share of Cartridges, 2020-2030
      • 9.9.2.5. Isolator based Aseptic Filling Systems Market in Europe: Share of Syringes, 2020-2030
      • 9.9.2.6. Isolator based Aseptic Filling Systems Market in Europe: Share of Vials, 2020-2030
      • 9.9.2.7. Isolator based Aseptic Filling Systems Market in Europe: Share of Other Primary Containers, 2020-2030
    • 9.9.3. Isolator based Aseptic Filling Systems Market in Europe: Distribution by System Throughput, 2020-2030
      • 9.9.3.1. Isolator based Aseptic Filling Systems Market in Europe: Share of Low Throughput Systems, 2020-2030
      • 9.9.3.2. Isolator based Aseptic Filling Systems Market in Europe: Share of Medium Throughput Systems, 2020-2030
      • 9.9.3.3. Isolator based Aseptic Filling Systems Market in Europe: Share of High Throughput Systems, 2020-2030
    • 9.9.4. Isolator based Aseptic Filling Systems Market in Europe: Distribution by End-User, 2020-2030
      • 9.9.4.1. Isolator based Aseptic Filling Systems Market in Europe: Share of Contract Service Providers, 2020-2030
      • 9.9.4.2. Isolator based Aseptic Filling Systems Market in Europe: Share of Pharmaceutical Companies, 2020-2030
      • 9.9.4.3. Isolator based Aseptic Filling Systems Market in Europe: Share of Other End-Users, 2020-2030
  • 9.10. Overall Isolator based Aseptic Filling Systems Market in Asia-Pacific, 2020-2030
    • 9.10.1. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Distribution by Scale of Operation, 2020-2030
      • 9.10.1.1. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Clinical Scale Systems, 2020-2030
      • 9.10.1.2. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Commercial Scale Systems, 2020-2030
    • 9.10.2. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Distribution by Type of Compatible Primary Container, 2020-2030
      • 9.10.2.1. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Ampoules, 2020-2030
      • 9.10.2.2. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Bottles, 2020-2030
      • 9.10.2.3. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Capsules, 2020-2030
      • 9.10.2.4. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Cartridges, 2020-2030
      • 9.10.2.5. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Syringes, 2020-2030
      • 9.10.2.6. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Vials, 2020-2030
      • 9.10.2.7. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Other Primary Containers, 2020-2030
    • 9.10.3. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Distribution by System Throughput, 2020-2030
      • 9.10.3.1. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Low Throughput Systems, 2020-2030
      • 9.10.3.2. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Medium Throughput Systems, 2020-2030
      • 9.10.3.3. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of High Throughput Systems, 2020-2030
    • 9.10.4. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Distribution by End-User, 2020-2030
      • 9.10.4.1. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Contract Service Providers, 2020-2030
      • 9.10.4.2. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Pharmaceutical Companies, 2020-2030
      • 9.10.4.3. Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Other End-Users, 2020-2030
  • 9.11. Overall Isolator based Aseptic Filling Systems Market in Rest of the World, 2020-2030
    • 9.11.1. Isolator based Aseptic Filling Systems Market in Rest of the World: Distribution by Scale of Operation, 2020-2030
      • 9.11.1.1. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Clinical Scale Systems, 2020-2030
      • 9.11.1.2. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Commercial Scale Systems, 2020-2030
    • 9.11.2. Isolator based Aseptic Filling Systems Market in Rest of the World: Distribution by Type of Compatible Primary Container, 2020-2030
      • 9.11.2.1. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Ampoules, 2020-2030
      • 9.11.2.2. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Bottles, 2020-2030
      • 9.11.2.3. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Capsules, 2020-2030
      • 9.11.2.4. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Cartridges, 2020-2030
      • 9.11.2.5. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Syringes, 2020-2030
      • 9.11.2.6. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Vials, 2020-2030
      • 9.11.2.7. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Other Primary Containers, 2020-2030
    • 9.11.3. Isolator based Aseptic Filling Systems Market in Rest of the World: Distribution by System Throughput, 2020-2030
      • 9.11.3.1. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Low Throughput Systems, 2020-2030
      • 9.11.3.2. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Medium Throughput Systems, 2020-2030
      • 9.11.3.3. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of High Throughput Systems, 2020-2030
    • 9.11.4. Isolator based Aseptic Filling Systems Market in Rest of the World: Distribution by End-User, 2020-2030
      • 9.11.4.1. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Contract Service Providers, 2020-2030
      • 9.11.4.2. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Pharmaceutical Companies, 2020-2030
      • 9.11.4.3. Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Other End-Users, 2020-2030

10. CONCLUSION

  • 10.1. Chapter Overview
  • 10.2. Key Takeaways

11. EXECUTIVE INSIGHTS

  • 11.1. Chapter Overview
  • 11.2. Automated Systems of Tacoma (AST)
    • 11.2.1. Interview Transcript: Joe Hoff, Chairman and CEO

12. APPENDIX 1: TABULATED DATA

13. APPENDIX 2: LIST OF COMPANIES AND ORGANISATIONS

List Of Figures

  • Figure 3.1 Drug Fill / Finish Process
  • Figure 3.2 Aseptic Fill / Finish Workflow
  • Figure 3.3 Comparison of Traditional Filling with Blow / Fill / Seal Technologies
  • Figure 3.4 Aseptic Processing Equipment and Degrees of Sterility
  • Figure 3.5 Comparison of RABS with Isolators
  • Figure 4.1 Isolator based Aseptic Filling Systems: Distribution by Type of System
  • Figure 4.2 Isolator based Aseptic Filling Systems: Distribution by Scale of Operation
  • Figure 4.3 Isolator based Aseptic Filling Systems: Distribution by System Throughput
  • Figure 4.4 Isolator based Aseptic Filling Systems: Distribution by Compatible Primary Container(s)
  • Figure 4.5 Grid Map Analysis by System Throughput and Compatible Primary Container
  • Figure 4.6 Isolator based Aseptic Filling Systems: Distribution by Type of Formulation
  • Figure 4.7 Isolator based Aseptic Filling Systems: Distribution by Fill Volume Range
  • Figure 4.8 Isolator based Aseptic Filling System Providers: Distribution by Year of Establishment
  • Figure 4.9 Isolator based Aseptic Filling System Providers: Distribution by Company Size
  • Figure 4.10 Logo Landscape of System Developers: Distribution by Company Size
  • Figure 4.11 Isolator based Aseptic Filling System Providers: Distribution by Geography
  • Figure 4.12 Leading Players: Distribution by Number of Proprietary Systems
  • Figure 5.1 Competitiveness Analysis: Products in Peer Group I
  • Figure 5.2 Competitiveness Analysis: Products in Peer Group II
  • Figure 5.3 Competitiveness Analysis: Products in Peer Group III
  • Figure 7.1 Partnerships and Collaborations: Distribution by Year of Partnership
  • Figure 7.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 7.3 Partnerships and Collaborations: Distribution by Focus Area
  • Figure 7.4 Most Active Players: Distribution by Number of Partnerships
  • Figure 7.5 Recent Conferences: Distribution by Year of Occurrence
  • Figure 7.6 Recent Conferences: Distribution by Geographical Location
  • Figure 8.1 Airborne Particulate Classification for Different Cleanroom Grades
  • Figure 9.1 Overall Isolator based Aseptic Filling Systems Market (USD Million), 2020-2030
  • Figure 9.2 Overall Isolator based Aseptic Filling Systems Market: Distribution by Scale of Operation (USD Million), 2020-2030
  • Figure 9.3 Overall Isolator based Aseptic Filling Systems Market: Distribution by Type of Compatible Primary Container (USD Million), 2020-2030
  • Figure 9.4 Overall Isolator based Aseptic Filling Systems Market: Distribution by System Throughput (USD Million), 2020-2030
  • Figure 9.5 Overall Isolator based Aseptic Filling Systems Market: Distribution by End- User (USD Million), 2020-2030
  • Figure 9.6 Isolator based Aseptic Filling Systems Market in North America: Share of Clinical Scale Systems (USD Million), 2020-2030
  • Figure 9.7 Isolator based Aseptic Filling Systems Market in North America: Share of Commercial Scale Systems (USD Million), 2020-2030
  • Figure 9.8 Isolator based Aseptic Filling Systems Market in North America: Share of Ampoules (USD Million), 2020-2030
  • Figure 9.9 Isolator based Aseptic Filling Systems Market in North America: Share of Bottles (USD Million), 2020-2030
  • Figure 9.10 Isolator based Aseptic Filling Systems Market in North America: Share of Capsules (USD Million), 2020-2030
  • Figure 9.11 Isolator based Aseptic Filling Systems Market in North America: Share of Cartridges (USD Million), 2020-2030
  • Figure 9.12 Isolator based Aseptic Filling Systems Market in North America: Share of Syringes (USD Million), 2020-2030
  • Figure 9.13 Isolator based Aseptic Filling Systems Market in North America: Share of Vials (USD Million), 2020-2030
  • Figure 9.14 Isolator based Aseptic Filling Systems Market in North America: Share of Other Primary Containers (USD Million), 2020-2030
  • Figure 9.15 Isolator based Aseptic Filling Systems Market in North America: Share of Low Throughput Systems (USD Million), 2020-2030
  • Figure 9.16 Isolator based Aseptic Filling Systems Market in North America: Share of Medium Throughput Systems (USD Million), 2020-2030
  • Figure 9.17 Isolator based Aseptic Filling Systems Market in North America: Share of High Throughput Systems (USD Million), 2020-2030
  • Figure 9.18 Isolator based Aseptic Filling Systems Market in North America: Share of Contract Service Providers (USD Million), 2020-2030
  • Figure 9.19 Isolator based Aseptic Filling Systems Market in North America: Share of Pharmaceutical Companies (USD Million), 2020-2030
  • Figure 9.20 Isolator based Aseptic Filling Systems Market in Europe: Share of Other End-Users (USD Million), 2020-2030
  • Figure 9.21 Isolator based Aseptic Filling Systems Market in Europe: Share of Clinical Scale Systems (USD Million), 2020-2030
  • Figure 9.22 Isolator based Aseptic Filling Systems Market in Europe: Share of Commercial Scale Systems (USD Million), 2020-2030
  • Figure 9.23 Isolator based Aseptic Filling Systems Market in Europe: Share of Ampoules (USD Million), 2020-2030
  • Figure 9.24 Isolator based Aseptic Filling Systems Market in Europe: Share of Bottles (USD Million), 2020-2030
  • Figure 9.25 Isolator based Aseptic Filling Systems Market in Europe: Share of Capsules (USD Million), 2020-2030
  • Figure 9.26 Isolator based Aseptic Filling Systems Market in Europe: Share of Cartridges (USD Million), 2020-2030
  • Figure 9.27 Isolator based Aseptic Filling Systems Market in Europe: Share of Syringes, (USD Million), 2020-2030
  • Figure 9.28 Isolator based Aseptic Filling Systems Market in Europe: Share of Vials, (USD Million), 2020-2030
  • Figure 9.29 Isolator based Aseptic Filling Systems Market in Europe: Share of Other Primary Containers (USD Million), 2020-2030
  • Figure 9.30 Isolator based Aseptic Filling Systems Market in Europe: Share of Low Throughput Systems (USD Million), 2020-2030
  • Figure 9.31 Isolator based Aseptic Filling Systems Market in Europe: Share of Medium Throughput Systems (USD Million), 2020-2030
  • Figure 9.32 Isolator based Aseptic Filling Systems Market in Europe: Share of High Throughput Systems (USD Million), 2020-2030
  • Figure 9.33 Isolator based Aseptic Filling Systems Market in Europe: Share of Contract Service Providers (USD Million), 2020-2030
  • Figure 9.34 Isolator based Aseptic Filling Systems Market in Europe: Share of Pharmaceutical Companies (USD Million), 2020-2030
  • Figure 9.35 Isolator based Aseptic Filling Systems Market in Europe: Share of Other End-Users (USD Million), 2020-2030
  • Figure 9.36 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Clinical Scale Systems (USD Million), 2020-2030
  • Figure 9.37 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Commercial Scale Systems (USD Million), 2020-2030
  • Figure 9.38 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Ampoules (USD Million), 2020-2030
  • Figure 9.39 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Bottles (USD Million), 2020-2030
  • Figure 9.40 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Capsules (USD Million), 2020-2030
  • Figure 9.41 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Cartridges (USD Million), 2020-2030
  • Figure 9.42 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Syringes (USD Million), 2020-2030
  • Figure 9.43 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Vials (USD Million), 2020-2030
  • Figure 9.44 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Other Primary Containers (USD Million), 2020-2030
  • Figure 9.45 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Low Throughput Systems (USD Million), 2020-2030
  • Figure 9.46 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Medium Throughput Systems (USD Million), 2020-2030
  • Figure 9.47 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of High Throughput Systems (USD Million), 2020-2030
  • Figure 9.48 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Contract Service Providers (USD Million), 2020-2030
  • Figure 9.49 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Pharmaceutical Companies (USD Million), 2020-2030
  • Figure 9.50 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Other End-Users (USD Million), 2020-2030
  • Figure 9.51 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Clinical Scale Systems (USD Million), 2020-2030
  • Figure 9.52 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Commercial Scale Systems (USD Million), 2020-2030
  • Figure 9.53 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Ampoules (USD Million), 2020-2030
  • Figure 9.54 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Bottles (USD Million), 2020-2030
  • Figure 9.55 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Capsules (USD Million), 2020-2030
  • Figure 9.56 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Cartridges (USD Million), 2020-2030
  • Figure 9.57 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Syringes (USD Million), 2020-2030
  • Figure 9.58 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Vials (USD Million), 2020-2030
  • Figure 9.59 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Other Primary Containers (USD Million), 2020-2030
  • Figure 9.60 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Low Throughput Systems (USD Million), 2020-2030
  • Figure 9.61 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Medium Throughput Systems (USD Million), 2020-2030
  • Figure 9.62 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of High Throughput Systems (USD Million), 2020-2030
  • Figure 9.63 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Contract Service Providers (USD Million), 2020-2030
  • Figure 9.64 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Pharmaceutical Companies (USD Million), 2020-2030
  • Figure 9.65 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Other End-Users (USD Million), 2020-2030

List Of Tables

  • Table 4.1 Isolator based Aseptic Filling Systems: Information on Developer, Type of System and Scale of Operation
  • Table 4.2 Isolator based Aseptic Filling Systems: Information on System Throughput
  • Table 5.3 Isolator based Aseptic Filling Systems: Information on Compatible Primary Container(s)
  • Table 5.4 Isolator based Aseptic Filling Systems: Information on the Type of Formulation
  • Table 4.5 List of Companies Providing Isolator based Aseptic Filling Systems
  • Table 6.1 AST: Company Snapshot
  • Table 6.2 AST: Recent Developments and Future Outlook
  • Table 6.3 Bausch+Ströbel: Company Snapshot
  • Table 6.4 Bausch+Ströbel: Recent Developments and Future Outlook
  • Table 6.5 Dara Pharmaceutical Packaging: Company Snapshot
  • Table 6.6 Dara Pharmaceutical Packaging: Recent Developments and Future Outlook
  • Table 6.7 Groninger: Company Snapshot
  • Table 6.8 Groninger: Recent Developments and Future Outlook
  • Table 6.9 IMA Group: Company Snapshot
  • Table 6.10 IMA Group: Recent Developments and Future Outlook
  • Table 6.11 Marchesini Group: Company Snapshot
  • Table 6.12 Marchesini Group: Recent Developments and Future Outlook
  • Table 6.13 OPTIMA Packaging Group: Company Snapshot
  • Table 6.14 OPTIMA Packaging Group: Recent Developments and Future Outlook
  • Table 6.15 Syntegon: Company Snapshot
  • Table 6.16 Syntegon: Recent Developments and Future Outlook
  • Table 6.17 Tofflon Group: Company Snapshot
  • Table 6.18 Tofflon Group: Recent Developments and Future Outlook
  • Table 6.19 Vanrx Pharmasystems: Company Snapshot
  • Table 6.20 Vanrx Pharmasystems: Recent Developments and Future Outlook
  • Table 7.1 Isolator based Aseptic Filling Systems: List of Partnerships and Collaborations, 2017-2020
  • Table 7.2 Isolator based Aseptic Filling Systems: List of Conferences, 2017-2020
  • Table 12.1 Isolator based Aseptic Filling Systems: Distribution by Type of System
  • Table 12.2 Isolator based Aseptic Filling Systems: Distribution by Scale of Operation
  • Table 12.3 Isolator based Aseptic Filling Systems: Distribution by System Throughput
  • Table 12.4 Isolator based Aseptic Filling Systems: Distribution by Compatible Primary Container(s)
  • Table 12.5 Isolator based Aseptic Filling Systems: Distribution by Type of Formulation
  • Table 12.6 Isolator based Aseptic Filling Systems: Distribution by Fill Volume Range
  • Table 12.8 Isolator based Aseptic Filling System Providers: Distribution by Year of Establishment
  • Table 12.9 Isolator based Aseptic Filling System Providers: Distribution by Company Size
  • Table 12.10 Isolator based Aseptic Filling System Providers: Distribution by Geography
  • Table 12.11 Isolator based Aseptic Filling Systems Market Partnership Activity: Analysis by Year of Partnership
  • Table 12.12 Isolator based Aseptic Filling Systems Market Partnership Activity: Analysis by Type of Partnership
  • Table 12.14 Isolator based Aseptic Filling Systems Market Partnership: Analysis by Number of Partnerships
  • Table 12.15 Isolator based Aseptic Filling Systems Market Recent Conferences: Analysis by Year of Occurrence
  • Table 12.16 Isolator based Aseptic Filling Systems Market Recent Conferences: Analysis by Geographical Location
  • Table 12.17 Overall Isolator based Aseptic Filling Systems Market (USD Million), 2020-2030
  • Table 12.18 Overall Isolator based Aseptic Filling Systems Market: Distribution by Scale of Operation (USD Million), 2020-2030
  • Table 12.19 Overall Isolator based Aseptic Filling Systems Market: Distribution by Type of Compatible Primary Container (USD Million), 2020-2030
  • Table 12.20 Overall Isolator based Aseptic Filling Systems Market: Distribution by System Throughput (USD Million), 2020-2030
  • Table 12.21 Overall Isolator based Aseptic Filling Systems Market: Distribution by End- User (USD Million), 2020-2030
  • Table 12.22 Isolator based Aseptic Filling Systems Market in North America: Share of Clinical Scale Systems (USD Million), 2020-2030
  • Table 12.23 Isolator based Aseptic Filling Systems Market in North America: Share of Commercial Scale Systems (USD Million), 2020-2030
  • Table 12.24 Isolator based Aseptic Filling Systems Market in North America: Share of Ampoules (USD Million), 2020-2030
  • Table 12.25 Isolator based Aseptic Filling Systems Market in North America: Share of Bottles (USD Million), 2020-2030
  • Table 12.26 Isolator based Aseptic Filling Systems Market in North America: Share of Capsules (USD Million), 2020-2030
  • Table 12.27 Isolator based Aseptic Filling Systems Market in North America: Share of Cartridges (USD Million), 2020-2030
  • Table 12.28 Isolator based Aseptic Filling Systems Market in North America: Share of Syringes (USD Million), 2020-2030
  • Table 12.29 Isolator based Aseptic Filling Systems Market in North America: Share of Vials (USD Million), 2020-2030
  • Table 12.30 Isolator based Aseptic Filling Systems Market in North America: Share of Other Primary Containers (USD Million), 2020-2030
  • Table 12.31 Isolator based Aseptic Filling Systems Market in North America: Share of Low Throughput Systems (USD Million), 2020-2030
  • Table 12.32 Isolator based Aseptic Filling Systems Market in North America: Share of Medium Throughput Systems (USD Million), 2020-2030
  • Table 12.33 Isolator based Aseptic Filling Systems Market in North America: Share of High Throughput Systems (USD Million), 2020-2030
  • Table 12.34 Isolator based Aseptic Filling Systems Market in North America: Share of Contract Service Providers (USD Million), 2020-2030
  • Table 12.35 Isolator based Aseptic Filling Systems Market in North America: Share of Pharmaceutical Companies (USD Million), 2020-2030
  • Table 12.36 Isolator based Aseptic Filling Systems Market in Europe: Share of Clinical Other End-Users (USD Million), 2020-2030
  • Table 12.37 Isolator based Aseptic Filling Systems Market in Europe: Share of Clinical Scale Systems (USD Million), 2020-2030
  • Table 12.38 Isolator based Aseptic Filling Systems Market in Europe: Share of Commercial Scale Systems (USD Million), 2020-2030
  • Table 12.39 Isolator based Aseptic Filling Systems Market in Europe: Share of Ampoules (USD Million), 2020-2030
  • Table 12.40 Isolator based Aseptic Filling Systems Market in Europe: Share of Bottles (USD Million), 2020-2030
  • Table 12.41 Isolator based Aseptic Filling Systems Market in Europe: Share of Capsules (USD Million), 2020-2030
  • Table 12.42 Isolator based Aseptic Filling Systems Market in Europe: Share of Cartridges (USD Million), 2020-2030
  • Table 12.43 Isolator based Aseptic Filling Systems Market in Europe: Share of Syringes (USD Million), 2020-2030
  • Table 12.44 Isolator based Aseptic Filling Systems Market in Europe: Share of Vials (USD Million), 2020-2030
  • Table 12.45 Isolator based Aseptic Filling Systems Market in Europe: Share of Other Primary Containers (USD Million), 2020-2030
  • Table 12.46 Isolator based Aseptic Filling Systems Market in Europe: Share of Low Throughput Systems (USD Million), 2020-2030
  • Table 12.47 Isolator based Aseptic Filling Systems Market in Europe: Share of Medium Throughput Systems (USD Million), 2020-2030
  • Table 12.48 Isolator based Aseptic Filling Systems Market in Europe: Share of High Throughput Systems (USD Million), 2020-2030
  • Table 12.49 Isolator based Aseptic Filling Systems Market in Europe: Share of Contract Service Providers (USD Million), 2020-2030
  • Table 12.50 Isolator based Aseptic Filling Systems Market in Europe: Share of Pharmaceutical Companies (USD Million), 2020-2030
  • Table 12.51 Isolator based Aseptic Filling Systems Market in Europe: Share of Other End-Users (USD Million), 2020-2030
  • Table 12.52 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Clinical Scale Systems (USD Million), 2020-2030
  • Table 12.53 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Commercial Scale Systems (USD Million), 2020-2030
  • Table 12.54 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Ampoules (USD Million), 2020-2030
  • Table 12.55 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Bottles (USD Million), 2020-2030
  • Table 12.56 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Capsules (USD Million), 2020-2030
  • Table 12.57 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Cartridges, 2020-2030
  • Table 12.58 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Syringes (USD Million), 2020-2030
  • Table 12.59 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Vials (USD Million), 2020-2030
  • Table 12.60 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Other Primary Containers (USD Million), 2020-2030
  • Table 12.61 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Low Throughput Systems (USD Million), 2020-2030
  • Table 12.62 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Medium Throughput Systems (USD Million), 2020-2030
  • Table 12.63 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of High Throughput Systems (USD Million), 2020-2030
  • Table 12.64 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Contract Service Providers (USD Million), 2020-2030
  • Table 12.65 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Pharmaceutical Companies (USD Million), 2020-2030
  • Table 12.66 Isolator based Aseptic Filling Systems Market in Asia-Pacific: Share of Other End-Users (USD Million), 2020-2030
  • Table 12.67 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Clinical Scale Systems (USD Million), 2020-2030
  • Table 12.68 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Commercial Scale Systems (USD Million), 2020-2030
  • Table 12.69 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Ampoules (USD Million), 2020-2030
  • Table 12.70 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Bottles (USD Million), 2020-2030
  • Table 12.71 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Capsules (USD Million), 2020-2030
  • Table 12.72 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Cartridges (USD Million), 2020-2030
  • Table 12.73 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Syringes (USD Million), 2020-2030
  • Table 12.74 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Vials (USD Million), 2020-2030
  • Table 12.75 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Other Primary Containers (USD Million), 2020-2030
  • Table 12.76 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Low Throughput Systems (USD Million), 2020-2030
  • Table 12.77 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Medium Throughput Systems (USD Million), 2020-2030
  • Table 12.78 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of High Throughput Systems (USD Million), 2020-2030
  • Table 12.79 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Contract Service Providers (USD Million), 2020-2030
  • Table 12.80 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Pharmaceutical Companies (USD Million), 2020-2030
  • Table 12.81 Isolator based Aseptic Filling Systems Market in Rest of the World: Share of Other End-Users (USD Million), 2020-2030

List Of Company

The following companies and organizations have been mentioned in the report.

  • 1. ACG
  • 2. ACIC Pharmaceutical Machinery
  • 3. Advaxis
  • 4. Aflex Hose
  • 5. Ambica Pharma Machines
  • 6. Anchor Mark
  • 7. Antares Vision
  • 8. ARaymondlife
  • 9. Argonaut Manufacturing Services
  • 10. Aseptic Technologies
  • 11. Auteco Sistemi
  • 12. Automated Systems of Tacoma (AST)
  • 13. AWS Bio-Pharma Technologies
  • 14. AXOMATIC
  • 15. BAUSCH Advanced Technology Group
  • 16. Bausch+Ströbel
  • 17. Bosch Packaging Technology
  • 18. Carlo Corazza
  • 19. Catalent
  • 20. Charles Thompson
  • 21. CMP PHAR.MA
  • 22. Comecer
  • 23. COOLVACUUM Technologies
  • 24. CPi Technology
  • 25. Creinox
  • 26. CVC Capital Partners
  • 27. Daikyo Seiko
  • 28. Dara Pharma
  • 29. Extract Technology
  • 30. FUJIFILM Diosynth Biotechnologies
  • 31. G-CON Manufacturing
  • 32. GEA Group
  • 33. Getinge
  • 34. gmp-experts Beratungs
  • 35. groninger
  • 36. Harro Höfliger
  • 37. i-Dositecno
  • 38. IMA Group
  • 39. Inno4Life
  • 40. Klenzaids
  • 41. LG Life Sciences
  • 42. Libbs Farmaceutica
  • 43. M&O Perry Industries
  • 44. Maier Packaging
  • 45. Marchesini Group
  • 46. Martin Christ Freeze Dryers
  • 47. Massachusetts Institute of Technology
  • 48. MEDInstill
  • 49. Netsteril
  • 50. NJM Packaging
  • 51. Nova Laboratories
  • 52. OPTIMA
  • 53. PennTech Machinery
  • 54. Pfizer
  • 55. Pharmaceutics International (Pii)
  • 56. Quality Machines
  • 57. Romaco
  • 58. ROTA
  • 59. säntis Packaging
  • 60. Schematic Engineering Industries
  • 61. Schmucker
  • 62. SCHOTT KAISHA
  • 63. SEA Vision
  • 64. Shanghai Divine Medical Technology
  • 65. Shanghai Jianzhong Medical Packaging
  • 66. Shibuya
  • 67. Shilpa Medicare
  • 68. Shree Bhagwati Machtech
  • 69. Singota Solutions
  • 70. SKAN
  • 71. Snowbell Machines
  • 72. SP Scientific
  • 73. SPIMACO
  • 74. Steriline
  • 75. Stevanato Group
  • 76. Syntegon
  • 77. TELSTAR
  • 78. Terra Asia Consulting
  • 79. Thai Industrial Pharmacist Association (TIPA)
  • 80. Tofflon
  • 81. TRUKING TECHNOLOGY
  • 82. Vanrx Pharmasystems
  • 83. Vibrotech
  • 84. VITRONIC Machine Vision
  • 85. Watson-Marlow Fluid Technology Group
  • 86. Wipf